Trademark: 88787860
Word
BITIDE
Status
Dead
Status Code
606
Status Date
Monday, February 28, 2022
Serial Number
88787860
Mark Type
4000
Filing Date
Thursday, February 6, 2020
Published for Opposition
Tuesday, June 2, 2020
Abandoned Date
Monday, February 28, 2022

Trademark Owner History
Leidos, Inc. - Owner At Publication

Classifications
5 Pharmaceutical peptide preparations for use in treating cancer, infectious diseases, and central nervous system disorders, consisting of peptide-based PD1 blockade inhibitors linked together by a molecular spacer to create a Bi-Specific Drug, used in combination with recombinant vaccines

Trademark Events
Feb 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 28, 2022
Abandonment - No Use Statement Filed
Jul 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2021
Extension 2 Granted
Jul 26, 2021
Extension 2 Filed
Jul 26, 2021
Teas Extension Received
Jan 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2021
Extension 1 Granted
Jan 11, 2021
Extension 1 Filed
Jan 11, 2021
Teas Extension Received
Jul 28, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 28, 2020
Approved For Pub - Principal Register
Apr 25, 2020
Assigned To Examiner
Feb 10, 2020
New Application Office Supplied Data Entered In Tram
Feb 10, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24